Shilpa Medicare CFO resigns
The commercial production in the SML was started in November 1989.
The commercial production in the SML was started in November 1989.
This license is a key regulatory milestone in advancing Hester's prevention-led poultry healthcare portfolio
InflaRx is streamlining operations and largely discontinuing non-essential activities outside izicopan’s development
Astal estimates the collaboration will generate incremental revenue of approximately Rs. 300 crore upon implementation
The decision is based on robust clinical evidence from the VOYAGE and EXCURSION studies
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Now a test that offers new precision in prostate cancer detection
Soficitinib is a potent and selective TYK2 inhibitor under development for multiple T-cell mediated autoimmune disorders
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
Subscribe To Our Newsletter & Stay Updated